Literature DB >> 6494476

Untreated Paget disease of bone studied by scintigraphy.

C J Vellenga, E K Pauwels, O L Bijvoet, W B Frijlink, J D Mulder, J Hermans.   

Abstract

We determined that the concentration of radioactivity in a lesion of Paget disease correlates with the grade of radiological deformation and the frequency of pain; the total skeletal uptake correlates with the severity of the biochemical abnormalities. We suggest that the major determinant of uptake in untreated lesions is abnormal metabolic activity, and in lesions in remission it is structural deformation of mineralized tissue. It is likely that the metabolic activity, and possibly also the rate of progression of the individual lesions, will differ in the individual patient, and that metabolic activity determines the amount of deformation and the chance of pain. Lesions not visible on the radiograph usually show only low uptake of Tc-99m-Sn-EHDP; the majority of these lesions are asymptomatic and reflect low activity of the disease. Radiological differentiation between sclerotic and osteolytic lesions does not reflect differences in either scintigraphic uptake, metabolic activity, or pain.

Entities:  

Mesh:

Year:  1984        PMID: 6494476     DOI: 10.1148/radiology.153.3.6494476

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  10 in total

1.  Paget's disease of bone or osteopetrosis?

Authors:  Alexander Rozin; Rachel Bar-Shalom; Sofia Ish-Shalom
Journal:  Clin Rheumatol       Date:  2005-10-19       Impact factor: 2.980

Review 2.  Best practice in primary care pathology: review 5.

Authors:  W S A Smellie; J Forth; S Ryder; M J Galloway; A C Wood; I D Watson
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

Review 3.  Management of Paget's disease of bone.

Authors:  I R Reid
Journal:  Osteoporos Int       Date:  2019-12-17       Impact factor: 4.507

Review 4.  Paget's disease of bone: review with emphasis on radiologic features, Part I.

Authors:  J M Mirra; E W Brien; J Tehranzadeh
Journal:  Skeletal Radiol       Date:  1995-04       Impact factor: 2.199

Review 5.  Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  A Fitton; D McTavish
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

6.  Imaging features of Paget's disease on 11C choline PET/CT.

Authors:  Cameron E Leitch; Ajit H Goenka; Benjamin M Howe; Stephen M Broski
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

7.  Treatment of Paget's disease of bone with (4-chloro-phenyl) thiomethylene bisphosphonate.

Authors:  M Audran; P Clochon; D Etghen; B Mazieres; J C Renier
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

Review 8.  Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

9.  Hypercalcemia in a patient with a bowing femur.

Authors:  Maroua Slouma; Safa Rahmouni; Rim Dhahri; Maissa Abbes; Imen Gharsallah; Leila Metoui; Bassem Louzir
Journal:  Clin Case Rep       Date:  2020-11-23

10.  Paget's disease diagnosed on bone scintigraphy: Case report and literature review.

Authors:  Avs Anil Kumar; Pg Kumar; Ms Prakash; V Tewari; H Sahni; Ak Dash
Journal:  Indian J Nucl Med       Date:  2013-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.